Market Overview:
The global closantel sodium market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidences of parasitic infections, increasing demand for effective and affordable veterinary drugs, and growing awareness about animal health. By type, the global closantel sodium market is segmented into ≥98%, ≥99%, and other types. The ≥98% type segment is expected to account for a major share of the global closantel sodium market during the forecast period. This can be attributed to its high efficacy in treating parasitic infections in animals. By application, the global closantel sodium market is segmented into injection, powder, and other applications.
Product Definition:
Closantel Sodium is an anti-parasitic agent used in veterinary medicine to treat infections caused by cestodes (tapeworms) and nematodes (roundworms, hookworms, whipworms).
≥98%:
Closantel sodium is a type of anticoagulant rodenticide. It is used to control the population of rodents and other pests in agricultural fields, residential areas, commercial businesses, warehouses and institutions. The product has high demand as it can be used for more than one year with minimal storage requirements.
≥99%:
It is a type of antifungal medication used to treat ringworm, jock itch, and athlete's foot. It is also used on the scalp in some cases of fungal infections like ringworms and itchy scalp conditions.
Closantel sodium has been found to be very effective in treating these fungal infections when compared with other anti-fungal medications available today.
Application Insights:
Injection was the largest application segment and accounted for a volume share of over 80% in 2017. The product is used as an anti-cancer agent, which has led to its high demand injection form. In addition, it can be used as an alternative to 5-fluorouracil (5-FU), which is commonly used for the treatment of breast cancer. However, there are no approved clinical trials supporting this use and henceforth it cannot be considered a safe drug under prescription.
The powder version of closantel sodium is manufactured using 99% ethanolamine phosphate solution as a binder along with corn starch and stearic acid filler ingredients.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a growth rate of 5.6% over the forecast period, owing to rising cases of chronic kidney disease and increasing use of Closantel sodium for maintenance and prevention of diseases in patients with CKD stage 5 & 6. In addition, growing number of product launches coupled with high R&D expenditure by major companies is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to be one of fastest-growing regions during the forecast years due to factors such as improving healthcare infrastructure leading towards better treatment options for patients suffering from kidney disorders along with growing prevalence rates associated with hypertension and diabetes which are likely increase demand for Closantel sodium products in this region over next eight years.
Growth Factors:
- Increasing demand for Closantel Sodium in animal health industry as a result of growing awareness about the benefits of using this compound for disease prevention and treatment.
- Rising prevalence of livestock diseases, which is expected to fuel the demand for Closantel Sodium in the near future.
- Growing research and development activities aimed at discovering new applications of Closantel Sodium in various industries.
- Increasing investments by key players in manufacturing facilities to meet the rising global demand for this product.
Scope Of The Report
Report Attributes
Report Details
Report Title
Closantel Sodium Market Research Report
By Type
≥98%, ≥99%, Other
By Application
Injection, Powder, Other
By Companies
Lasa Laboratory, Adani Pharmachem Private Limited, Salus Nutra, Hubei Bangsheng Chemical, Jiangsu Quality Horizons Pharmtech, KPS Chemicals & Pharmaceuticals, Pitech Innovations, P I Drugs & Pharmaceuticals, Haikou Hengkangda Chem, S.R. Chemicals & Pharmaceuticals, Hubei Xingyinhe Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Closantel Sodium Market Report Segments:
The global Closantel Sodium market is segmented on the basis of:
Types
≥98%, ≥99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injection, Powder, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lasa Laboratory
- Adani Pharmachem Private Limited
- Salus Nutra
- Hubei Bangsheng Chemical
- Jiangsu Quality Horizons Pharmtech
- KPS Chemicals & Pharmaceuticals
- Pitech Innovations
- P I Drugs & Pharmaceuticals
- Haikou Hengkangda Chem
- S.R. Chemicals & Pharmaceuticals
- Hubei Xingyinhe Chemical
Highlights of The Closantel Sodium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥98%
- ≥99%
- Other
- By Application:
- Injection
- Powder
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Closantel Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Closantel Sodium is a medication used to treat infections caused by the protozoan parasite, Toxoplasma gondii. Closantel sodium is also known as TPG-1300.
Some of the key players operating in the closantel sodium market are Lasa Laboratory, Adani Pharmachem Private Limited, Salus Nutra, Hubei Bangsheng Chemical, Jiangsu Quality Horizons Pharmtech, KPS Chemicals & Pharmaceuticals, Pitech Innovations, P I Drugs & Pharmaceuticals, Haikou Hengkangda Chem, S.R. Chemicals & Pharmaceuticals, Hubei Xingyinhe Chemical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Closantel Sodium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Closantel Sodium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Closantel Sodium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Closantel Sodium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Closantel Sodium Market Size & Forecast, 2018-2028
4.5.1 Closantel Sodium Market Size and Y-o-Y Growth
4.5.2 Closantel Sodium Market Absolute $ Opportunity
Chapter 5 Global Closantel Sodium Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Closantel Sodium Market Size Forecast by Type
5.2.1 ≥98%
5.2.2 ≥99%
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Closantel Sodium Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Closantel Sodium Market Size Forecast by Applications
6.2.1 Injection
6.2.2 Powder
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Closantel Sodium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Closantel Sodium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Closantel Sodium Analysis and Forecast
9.1 Introduction
9.2 North America Closantel Sodium Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Closantel Sodium Market Size Forecast by Type
9.6.1 ≥98%
9.6.2 ≥99%
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Closantel Sodium Market Size Forecast by Applications
9.10.1 Injection
9.10.2 Powder
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Closantel Sodium Analysis and Forecast
10.1 Introduction
10.2 Europe Closantel Sodium Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Closantel Sodium Market Size Forecast by Type
10.6.1 ≥98%
10.6.2 ≥99%
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Closantel Sodium Market Size Forecast by Applications
10.10.1 Injection
10.10.2 Powder
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Closantel Sodium Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Closantel Sodium Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Closantel Sodium Market Size Forecast by Type
11.6.1 ≥98%
11.6.2 ≥99%
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Closantel Sodium Market Size Forecast by Applications
11.10.1 Injection
11.10.2 Powder
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Closantel Sodium Analysis and Forecast
12.1 Introduction
12.2 Latin America Closantel Sodium Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Closantel Sodium Market Size Forecast by Type
12.6.1 ≥98%
12.6.2 ≥99%
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Closantel Sodium Market Size Forecast by Applications
12.10.1 Injection
12.10.2 Powder
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Closantel Sodium Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Closantel Sodium Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Closantel Sodium Market Size Forecast by Type
13.6.1 ≥98%
13.6.2 ≥99%
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Closantel Sodium Market Size Forecast by Applications
13.10.1 Injection
13.10.2 Powder
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Closantel Sodium Market: Competitive Dashboard
14.2 Global Closantel Sodium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lasa Laboratory
14.3.2 Adani Pharmachem Private Limited
14.3.3 Salus Nutra
14.3.4 Hubei Bangsheng Chemical
14.3.5 Jiangsu Quality Horizons Pharmtech
14.3.6 KPS Chemicals & Pharmaceuticals
14.3.7 Pitech Innovations
14.3.8 P I Drugs & Pharmaceuticals
14.3.9 Haikou Hengkangda Chem
14.3.10 S.R. Chemicals & Pharmaceuticals
14.3.11 Hubei Xingyinhe Chemical
